The Scientific and Research Team at Arbutus Biopharma is responsible for driving the discovery and development of innovative therapies aimed at curing chronic hepatitis B infection. Comprising experts in medicinal chemistry, biology, immunology, and pharmacology, the team conducts cutting-edge research, develops new compounds, and translates scientific discoveries into clinical applications, ensuring rigorous analytical and preclinical testing to advance therapeutic candidates toward commercialization.
Amanda Pohl
Senior Associate, DMPK
Andrew Cole
Vice President, Chemistry
Angela M. Lam
Vp, Biology
Christine Espiritu
Sr. Scientist
Michael J. Sofia Phd
Chief Scientific Officer
Rajeev Singh
Analytical R&d - Process Devel...
Richard Holland
Senior Scientist
Seyma Ozturk Guliyev
Senior Scientist, Medicinal Ch...
Tim Eley
Vice President Clinical Pharma...
Troy Harasym
Vice President, DMPK & Transla...
View all